title: Features of Hepatitis in Hepatitis-associated Aplastic Anemia: Clinical and Histopathologic Study.
abstract: Hepatitis-associated aplastic anemia (HAA) is a rare variant of aplastic anemia in which patients present with severe pancytopenia after an episode of acute hepatitis. The marrow failure is often rapid, severe, and usually fatal if untreated. The preceding hepatitis is largely under-studied.
  
  
  
  Retrospective study of the clinical and histopathologic features of hepatitis in pediatric patients who subsequently developed aplastic anemia and comparison with consecutive cases of acute liver failure and random cases of autoimmune hepatitis during the same time frame.
  
  
  
  All 7 patients of HAA had significant elevations in aminotransferases and conjugated hyperbilirubinemia at initial presentation. Echoing liver function indices, cholestatic hepatitis with sinusoidal obstruction-type endothelial injury was seen histomorphologically. Autoimmune hepatitis serology such as anti-F-actin, anti-liver/kidney microsome, and hypergammaglobulinemia was negative in all patients. Five of 7 patients (71.4%) had, however, elevated antinuclear antibody, all with a speckled pattern. Hepatitis virus serology was negative in all patients. By immunohistochemical staining, the lobular CD8/CD4 lymphocyte ratio was markedly elevated in all of the initial samples with significant reduction in this ratio (P = 0.03) in 3 patients post treatment (ursodiol, antibiotics, and/or immunosuppressive therapy).
  
  
  
  Hepatitis preceding HAA is characterized by marked elevation of aminotransferases, conjugated hyperbilirubinemia, elevated antinuclear antibody with a speckled pattern, cholestatic hepatitis with sinusoidal obstruction morphology, and CD8 dominant lobular infiltrates. The present study suggests HAA may result from cytotoxic T-cell-mediated sinusoidal endothelial and hepatocytic injury.
authors.affiliation: *Department of Pathology†Section of Hematology‡Section of Hepatology of the Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston.
authors.forename: Kalyani R
authors.initials: KR
authors.lastname: Patel
authors.forename: Alison
authors.initials: A
authors.lastname: Bertuch
authors.forename: Ghadir S
authors.initials: GS
authors.lastname: Sasa
authors.forename: Ryan W
authors.initials: RW
authors.lastname: Himes
authors.forename: Hao
authors.initials: H
authors.lastname: Wu
mesh_terms: D000199:Actins / Q000037:antagonists & inhibitors; D000208:Acute Disease; D000293:Adolescent; D000741:Anemia, Aplastic / Q000097:blood / Q000150:complications / Q000473:pathology* / Q000628:therapy; D000974:Antibodies, Antinuclear / Q000097:blood*; D016516:CD4-CD8 Ratio; D002648:Child; D002675:Child, Preschool; D002779:Cholestasis / Q000209:etiology*; D005260:Female; D006505:Hepatitis / Q000097:blood / Q000150:complications / Q000473:pathology*; D019693:Hepatitis, Autoimmune / Q000097:blood / Q000473:pathology; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology*; D006942:Hypergammaglobulinemia / Q000209:etiology; D008099:Liver / Q000473:pathology; D017093:Liver Failure / Q000097:blood / Q000473:pathology; D008297:Male; D010198:Pancytopenia / Q000209:etiology; D012189:Retrospective Studies; D000637:Transaminases / Q000097:blood*
chemical_list: D000199:Actins; D000974:Antibodies, Antinuclear; D000637:Transaminases